The registration is only effective once on the Nasdaq though, right?
I also am of the opinion that much of the dillutive effect of the A/S increase is priced in.
Since the S1 is capped at 10 million, and hopefully sglb posts some surprising revenues on the upcoming ER, I suspect we will be diluted by at least 5 million shares bringing the total outstanding to ~11 million.
IF sglb posts revenues, to boost the pps before this upcoming dilution it will be much less painful, but when it's all said and done I suspect we will be around $2 a share with that 10 million in the bank and finally off the otc. All in all not a bad move at all.
If they don't have any good news to share before the S1, the dilution may hurt the short term pps a bit more but for all us longs, it's not necessarily a bad thing. Plenty of time to save some cash for the dilution. May even be able to make a quick flip if the pps rises enough after the next er before the dilution.